术前门静脉栓塞的争议
Controversies of preoperative portal vein embolization.
作者信息
May Benjamin J, Madoff David C
机构信息
Department of Radiology, Division of Interventional Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
出版信息
Hepat Oncol. 2016 Apr;3(2):155-166. doi: 10.2217/hep-2015-0004. Epub 2016 Mar 29.
Abstract
Portal vein embolization (PVE) is a safe, percutaneous procedure that has been proven to lower the complication rates of curative intent large-volume hepatic resection by inducing hypertrophy of the future liver remnant. While the safety and efficacy of PVE has been well substantiated, there remains controversy with regards to the technical details, periprocedural management, and whether alternative methods of achieving future liver remnant hypertrophy are preferable to PVE. This paper will address those controversies and offer recommendations based on available data.
摘要
门静脉栓塞术（PVE）是一种安全的经皮操作，已被证明可通过诱导未来肝剩余部分肥大来降低根治性大体积肝切除术的并发症发生率。虽然PVE的安全性和有效性已得到充分证实，但在技术细节、围手术期管理以及实现未来肝剩余部分肥大的替代方法是否比PVE更可取方面仍存在争议。本文将探讨这些争议，并根据现有数据提供建议。
相似文献
1
Controversies of preoperative portal vein embolization.术前门静脉栓塞的争议
Hepat Oncol. 2016 Apr;3(2):155-166. doi: 10.2217/hep-2015-0004. Epub 2016 Mar 29.
2
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.联合肝脏离断和门静脉结扎的分阶段肝切除术（ALPPS）：一种增加肝脏手术可切除性的新策略。
Int J Surg. 2014;12(5):437-41. doi: 10.1016/j.ijsu.2014.03.009. Epub 2014 Apr 2.
3
Preoperative portal vein embolization for major liver resection: a meta-analysis.肝大部切除术前门静脉栓塞术：一项荟萃分析
Ann Surg. 2008 Jan;247(1):49-57. doi: 10.1097/SLA.0b013e31815f6e5b.
4
Controversies in the use of portal vein embolization.门静脉栓塞术应用中的争议
Dig Surg. 2008;25(6):436-44. doi: 10.1159/000184735. Epub 2009 Feb 12.
5
Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.门静脉阻断后肝体积增加不足患者的挽救性肝实质离断术——ALPPS 方法的延伸。
Eur J Surg Oncol. 2013 Nov;39(11):1230-5. doi: 10.1016/j.ejso.2013.08.009. Epub 2013 Aug 29.
6
Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions.门静脉栓塞术在肝大部切除术前行选择性肝肥大诱导：原理、技术、结果及未来方向
Cancer Biol Med. 2016 Dec;13(4):426-442. doi: 10.20892/j.issn.2095-3941.2016.0083.
7
Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.门静脉结扎术作为在结直肠癌肝转移外科治疗中增加未来肝剩余体积的一种有效方法。
Arch Surg. 2008 Oct;143(10):978-82; discussion 982. doi: 10.1001/archsurg.143.10.978.
8
Rescue associating liver partition and portal vein ligation for staged hepatectomy after portal embolization: Our experience and literature review.门静脉栓塞后联合肝脏分隔与门静脉结扎的分期肝切除术：我们的经验及文献综述
World J Clin Oncol. 2017 Aug 10;8(4):351-359. doi: 10.5306/wjco.v8.i4.351.
9
Portal vein embolization: rationale, outcomes, controversies and future directions.门静脉栓塞术：原理、结果、争议和未来方向。
Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):489-501. doi: 10.1586/egh.10.41.
10
In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.原位劈裂加门静脉结扎术（ISLT）——一种在门静脉栓塞无效后进行的挽救性手术，目的是在扩大肝切除术前获得足够的未来肝残余体积。
BMC Surg. 2020 Apr 6;20(1):63. doi: 10.1186/s12893-020-00721-y.
引用本文的文献
1
Portal vein embolization with N-butyl-cyanoacrylate improves liver hypertrophy compared to microparticles - A Swedish multicenter cohort study.与微粒相比，使用氰基丙烯酸正丁酯进行门静脉栓塞可改善肝脏肥大——一项瑞典多中心队列研究。
Heliyon. 2023 Oct 22;9(11):e21210. doi: 10.1016/j.heliyon.2023.e21210. eCollection 2023 Nov.
2
Yttrium-90 Portal Vein Radioembolization in Sprague-Dawley Rats: Dose-Dependent Imaging and Pathological Changes in Normal Liver.钇-90 门静脉放射性栓塞在 Sprague-Dawley 大鼠中的应用：正常肝脏的剂量依赖性成像和病理变化。
Cardiovasc Intervent Radiol. 2020 Dec;43(12):1925-1935. doi: 10.1007/s00270-020-02614-2. Epub 2020 Aug 16.
本文引用的文献
1
A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection.门静脉结扎术与门静脉栓塞术用于择期肝切除术的系统评价和荟萃分析
Surgery. 2015 Apr;157(4):690-8. doi: 10.1016/j.surg.2014.12.009. Epub 2015 Feb 20.
2
Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?在结直肠癌肝转移的治疗中，我们能否改善与联合肝脏分隔和门静脉结扎分期肝切除术（ALPPS）相关的发病率和死亡率？
Surgery. 2015 Feb;157(2):194-201. doi: 10.1016/j.surg.2014.08.041. Epub 2014 Oct 1.
3
Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy.接受两阶段肝切除术患者右门静脉栓塞后2段和3段的体积再生
J Gastrointest Surg. 2015 Jan;19(1):133-41; discussion 141. doi: 10.1007/s11605-014-2617-y. Epub 2014 Aug 5.
4
ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.与传统分期肝切除术相比，ALPPS为原发性不可切除性肝肿瘤患者提供了更好的完整切除机会：一项多中心分析结果
World J Surg. 2014 Jun;38(6):1510-9. doi: 10.1007/s00268-014-2513-3.
5
Cancer statistics, 2014.癌症统计数据，2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
6
ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence.用于治疗结直肠癌肝转移患者的联合肝脏离断和门静脉结扎的二步肝切除术：有效的肝脏肥大，但早期肿瘤复发。
World J Surg. 2014 Jun;38(6):1504-9. doi: 10.1007/s00268-013-2401-2.
7
Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization.右肝放射性栓塞治疗后左肝肥大明显，但小于门静脉栓塞后。
Hepatology. 2014 May;59(5):1864-73. doi: 10.1002/hep.26947. Epub 2014 Apr 1.
8
Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy.门静脉栓塞后化疗以防止肝切除术前肝肥大期间肿瘤生长。
JAMA Surg. 2013 Dec;148(12):1103-8. doi: 10.1001/jamasurg.2013.2126.
9
A worldwide survey of the current daily practice in liver surgery.一项关于肝脏手术当前日常实践的全球调查。
Liver Cancer. 2013 Jan;2(1):55-66. doi: 10.1159/000346225.
10
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.放射叶切除术：不可切除肝癌作为切除桥接的未来剩余肝脏体积的时间依赖性分析。
J Hepatol. 2013 Nov;59(5):1029-36. doi: 10.1016/j.jhep.2013.06.015. Epub 2013 Jun 25.
Zotero 插件